Publications

Title

Author

Year

Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination.

Dunne, EM; Smith-Vaughan, HC; Robins-Browne, RM; MULHOLLAND, EK; Satzke, C;

2013

Vaccine, (2013).31 19 10.1016/j.vaccine.2013.03.024.

A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.

Draper, E; Bissett, SL; Howell-Jones, R; Waight, P; Soldan, K; JIT, M; Andrews, N; MILLER, E; Beddows, S;

2013

PloS one, (2013).8 5 10.1371/journal.pone.0061825.

Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda.

Proietti, C; Verra, F; Bretscher, MT; STONE, W; Kanoi, BN; Balikagala, B; Egwang, TG; CORRAN, P; Ronca, R; Arcà, B; RILEY, EM; Crisanti, A; DRAKELEY, C; BOUSEMA, T;

2013

Parasite immunology, (2013).35 5-6 10.1111/pim.12031.

Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.

CUCCUI, J; Thomas, RM; MOULE, MG; D'Elia, RV; Laws, TR; Mills, DC; Williamson, D; Atkins, TP; Prior, JL; WREN, BW;

2013

Open biology, (2013).3 5 10.1098/rsob.130002.

Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease.

Hargreaves, CE; Grasso, M; Hampe, CS; Stenkova, A; ATKINSON, S; JOSHUA, GW P; WREN, BW; Buckle, AM; Dunn-Walters, D; Banga, JP;

2013

Journal of immunology (Baltimore, Md, (2013).190 11 10.4049/jimmunol.1203412.

New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening.

Wang, SA; Hyde, TB; MOUNIER-JACK, S; Brenzel, L; Favin, M; Gordon, WS; Shearer, JC; Mantel, CF; Arora, N; Durrheim, D;

2013

Vaccine, (2013).31 Sup 0 2 10.1016/j.vaccine.2012.10.116.

The need for targeted implementation research to improve coverage of basic vaccines and introduction of new vaccines.

Arora, NK; Lal, AA; Hombach, JM; Santos, JI; Bhutta, ZA; Sow, SO; GREENWOOD, B;

2013

Vaccine, (2013).31 Sup SUPPL2 10.1016/j.vaccine.2013.01.058.

Group A streptococcal vaccines: paving a path for accelerated development.

Dale, JB; Fischetti, VA; Carapetis, JR; Steer, AC; Sow, S; Kumar, R; Mayosi, BM; Rubin, FA; MULHOLLAND, K; Hombach, JM; Schödel, F; Henao-Restrepo, AM;

2013

Vaccine, (2013).31 Sup SUPPL2 10.1016/j.vaccine.2012.09.045.

The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.

Lee, LA; Franzel, L; Atwell, J; Datta, SD; Friberg, IK; Goldie, SJ; Reef, SE; Schwalbe, N; Simons, E; Strebel, PM; Sweet, S; Suraratdecha, C; Tam, Y; VYNNYCKY, E; Walker, N; Walker, DG; Hansen, PM;

2013

Vaccine, (2013).31 Suppl 2, 10.1016/j.vaccine.2012.11.035.

Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.

Amarasinghe, A; Black, S; Bonhoeffer, J; Carvalho, SM D; Dodoo, A; Eskola, J; LARSON, H; Shin, S; Olsson, S; Balakrishnan, MR; Bellah, A; Lambach, P; Maure, C; Wood, D; Zuber, P; Akanmori, B; Bravo, P; Pombo, M; Langar, H; Pfeifer, D; Guichard, S; Diorditsa, S; Hossain, MS; Sato, Y;

2013

Vaccine, (2013).31 Suppl 2, 10.1016/j.vaccine.2012.10.119.